Skip to Content

Progesterone Injection

Last Updated: January 29, 2018
Status: Current

Progesterone Injection

Products Affected - Description
  • Progesterone intramuscular injection, American Regent
    50 mg/mL, 10 mL vial, 1 count (NDC 00517-0750-01)

 
Progesterone intramuscular injection, Fresenius Kabi
50 mg/mL, 10 mL vial, 1 count (NDC 63323-0261-10)

Progesterone intramuscular injection, Teva
50 mg/mL, 10 mL vial, 1 count (NDC 00591-3128-79)

Progesterone intramuscular injection, West-Ward
50 mg/mL, 10 mL vial, 1 count (NDC 00143-9725-01)
Reason for the Shortage
    • American Regent did not provide a reason for the shortage.
    • Fresenius Kabi has progesterone on shortage due to increased demand and manufacturing delays.
    • Teva has progesterone on shortage due to supply constraints.
    • West-Ward has progesterone on shortage due to manufacturing delays.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • American Regent has progesterone in oil 50 mg/mL 10 mL vials for intramuscular injection on back order and the company cannot estimate a release date.
    • Fresenius Kabi has progesterone in oil 50 mg/mL 10 mL vials for intramuscular injection on back order and the company cannot estimate a release date. Check wholesaler for availability.
    • Teva has progesterone in oil 50 mg/mL 10 mL vials for intramuscular injection on back order and the company estimates a release date of 2nd quarter 2018.
    • West-Ward has progesterone in oil 50 mg/mL 10 mL vials for intramuscular injection on back order and the company cannot estimate a release date.

Updated

January 29 and 24, 2018, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide